The FPCLASS list (http://dcv.uhnres.utoronto.ca/FPCLASS) included Mettl3 (Table S1), the writer of RNA modification N6-methyladenosine (m6A) with an important role in tumorigenesis and malignant progression in HCC. This evidence concerns the gene METTL3 and hepatocellular carcinoma.